Font: Financial Modeling Prep • May 20, 2026
Keysight Technologies, Inc. (NYSE: KEYS) is a leading technology company that provides advanced electronic design and test solutions. It serves various high-growth industries, including communications, aerospace, defense, and automotive. The company helps its customers design, test, and manufacture complex electronic products, solidifying its position as a key player in the global technology sector.
On May 19, 2026, Keysight Technologies reported strong second-quarter financial results after the market close. The company announced an earnings per share (EPS) of $2.87, which represents the profit earned for each share of stock. This impressive figure surpassed the analyst consensus estimate of $2.33, as noted by Zacks, and marks a significant increase from the $1.70 EPS reported a year ago, showcasing robust profitability growth.
In addition to strong earnings, Keysight Technologies posted impressive quarterly revenue of $1.72 billion. This amount was slightly above the consensus estimate of $1.71 billion. The revenue demonstrates significant top-line growth compared to the $1.31 billion generated in the same period last year, indicating a strong increase in sales performance for the company.
Following these positive results, Keysight Technologies shares climbed, as highlighted by Benzinga. CEO Satish Dhanasekaran described it as the "strongest quarter in the company's history." He pointed to all-time highs in orders, revenue, EPS, and free cash flow, according to a report from Business Wire, underscoring the company's exceptional market performance.
Looking at the company's robust financial health, Keysight Technologies has a debt-to-equity ratio of 0.44. This crucial financial ratio compares a company's total debt to its shareholder equity and suggests it uses less debt than equity to finance its assets, indicating prudent financial management. Its current ratio of 1.90 shows it can cover its short-term obligations almost twice over, highlighting strong liquidity.
|
LIMN§>
Liminatus Pharma, Inc. Class A Common Stock
|
$0.28
46.65%
|
|
SBFM§>
Sunshine Biopharma, Inc.
|
$0.51
38.55%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$8.52
-0.26%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.83
0.00%
|
|
NVDA§>
NVIDIA Corporation
|
$220.22
-1.46%
|
|
WOK§>
WORK Medical Technology Group Ltd.
|
$0.15
-20.74%
|
|
CXAI§>
CXApp Inc.
|
$0.21
20.28%
|
|
RGTI§>
Rigetti Computing, Inc.
|
$21.13
25.15%
|
|
NIVF§>
NewGenIvf Group Limited
|
$1.17
58.30%
|
|
NCPL§>
Netcapital Inc.
|
$0.67
47.85%
|